Abstract:Some human preimplantation embryos are chromosomally mosaic. For technical reasons, estimates of the overall frequency vary widely from <15 to >90% and the true frequency remains unknown. Aneuploid/diploid and aneuploid/aneuploid mosaics typically arise during early cleavage stages before the embryonic genome is fully activated and when cell cycle checkpoints are not operating normally. Other mosaics include chaotic aneuploid mosaics and mixoploids, some of which arise by abnormal chromosome segregation at the first cleavage division. Chimaeras are similar to mosaics, in having two genetically distinct cell populations, but they arise from more than one zygote and occur less often. After implantation, the frequency of mosaic embryos declines to about 2% and most are trisomic/diploid mosaics, with trisomic cells confined to the placenta. Thus, few babies are born with chromosomal mosaicism. This review discusses the origin of different types of chromosomal mosaics and chimaeras; their fate and the relationship between preimplantation chromosomal mosaicism and confined placental mosaicism in human conceptuses and animal models. Abnormal cells in mosaic embryos may be depleted by cell death, other types of cell selection or cell correction but the most severely affected mosaic embryos probably die. Trisomic cells could become restricted to placental lineages if cell selection or correction is less effective in placental lineages and/or they are preferentially allocated to a placental lineage. However, the relationship between preimplantation mosaicism and confined placental mosaicism may be complex because the specific chromosome(s) involved will influence whether chromosomally abnormal cells survive predominately in the placental trophoblast and/or placental mesenchyme. Lay summary: Human cells normally have 23 pairs of chromosomes, which carry the genes. During the first few days of development, some human embryos are chromosomal mosaics. These mosaic embryos have both normal cells and cells with an abnormal number of chromosomes, which arise from the same fertilised egg. (More rarely, the different cell populations arise from more than one fertilised egg and these embryos are called chimaeras.) If chromosomally abnormal cells survive to term, they could cause birth defects. However, few abnormal cells survive and those that do are usually confined to the placenta, where they are less likely to cause harm. It is not yet understood how this restriction occurs but the type of chromosomal abnormality influences which placental tissues are affected. This review discusses the origin of different types of chromosomally abnormal cells, their fate and how they might become confined to the placenta in humans and animal models.

Human embryonic genetic mosaicism and its effects on development and disease

Mosaicism in health and disease — clones picking up speed

Mosaicism in Human Health and Disease.

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

De novo mutations, genetic mosaicism and human disease

Regional and developmental characteristics of human embryo mosaicism revealed by single cell sequencing

Inherent mosaicism and extensive mutation of human placentas

Single-cell analysis of human embryos reveals diverse patterns of aneuploidy and mosaicism

The Clinical Spectrum of Mosaic Genetic Disease

Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential

Preimplantation chromosomal mosaics, chimaeras and confined placental mosaicism

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

Distinctive types of postzygotic single-nucleotide mosaicisms in healthy individuals revealed by genome-wide profiling of multiple organs

The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues

Characterization of early postzygotic somatic mutations through multi-organ analysis

Genomic Mosaicism Formed by Somatic Variation in the Aging and Diseased Brain

Somatic mosaicism and neurodevelopmental disease

Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism

From contemplation to classification of chromosomal mosaicism in human preimplantation embryos

Mosaic variegated aneuploidy in development, ageing and cancer

Identification of of a PAX2 Mutation from Maternal Mosaicism Causes Recurrent Renal Disorder in Siblings